Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products

D Wang, Y Yang, Y Lei, NT Tzvetkov… - Pharmacological …, 2019 - pharmrev.aspetjournals.org
Foam cell formation and further accumulation in the subendothelial space of the vascular
wall is a hallmark of atherosclerotic lesions. Targeting foam cell formation in the …

Acyl-coenzyme A: cholesterol acyltransferases

TY Chang, BL Li, CCY Chang… - American Journal of …, 2009 - journals.physiology.org
The enzymes acyl-coenzyme A (CoA): cholesterol acyltransferases (ACATs) are membrane-
bound proteins that utilize long-chain fatty acyl-CoA and cholesterol as substrates to form …

Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases

H Sheng, H Sun - Natural product reports, 2011 - pubs.rsc.org
Covering: up to May 2010 This review (with 335 references cited) is devoted to pentacyclic
triterpenes. The total synthesis, semi-synthesis, structural modification, and metabolic …

Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation

K Fon Tacer, D Rozman - Journal of lipids, 2011 - Wiley Online Library
Obesity with associated comorbidities is currently a worldwide epidemic and among the
most challenging health conditions in the 21st century. A major metabolic consequence of …

Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease

DE Cohen, EA Fisher - Seminars in liver disease, 2013 - thieme-connect.com
Cardiovascular disease represents the most common cause of death in patients with
nonalcoholic fatty liver disease (NAFLD). Patients with NAFLD exhibit an atherogenic …

Structural basis for catalysis and substrate specificity of human ACAT1

H Qian, X Zhao, R Yan, X Yao, S Gao, X Sun, X Du… - Nature, 2020 - nature.com
As members of the membrane-bound O-acyltransferase (MBOAT) enzyme family, acyl-
coenzyme A: cholesterol acyltransferases (ACATs) catalyse the transfer of an acyl group …

Natural products for controlling hyperlipidemia

WH El-Tantawy, A Temraz - Archives of physiology and …, 2019 - Taylor & Francis
Hyperlipidemia is an abnormality of lipid metabolism, characterized by an elevation of total
cholesterol, triglyceride, and low density lipoprotein-cholesterol, and/or a decreasing of high …

Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives

D He, M Wang, S Zhao, Y Shu, H Zeng, C Xiao, C Lu… - Fitoterapia, 2017 - Elsevier
Quinazolinones belong to a family of heterocyclic nitrogen compounds that have attracted
increasing interest because of their broad spectrum of biological functions. This review …

Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential

P Bhattacharjee, N Rutland, MR Iyer - Journal of Medicinal …, 2022 - ACS Publications
Sterol O-acyltransferase (SOAT) is a membrane-bound enzyme that aids the esterification of
cholesterol and fatty acids to cholesterol esters. SOAT has been studied extensively as a …

Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review

Y Cai, Q Yang, Y Yu, F Yang, R Bai… - Frontiers in pharmacology, 2023 - frontiersin.org
Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases,
which are increasing in prevalence. However, the failure of conventional lipid-lowering …